文献速递眼底病与葡萄膜炎

基线深层毛细血管丛缺血较中心凹无血管区扩大更早预测糖尿病视网膜病变并发症

Baseline Deep Capillary Plexus Ischemia Predicts Earlier Diabetic Retinopathy Complications Than Foveal Avascular Enlargement.
PubMed 文献 · Am J Ophthalmol · 2026-08-14

这项前瞻性观察队列研究纳入265只眼(175例患者),评估深层毛细血管丛几何灌注缺损(GPDd)和中心凹无血管区扩大(FAZe)对2年内糖尿病视网膜病变(DR)并发症风险与时机的预测价值。结果显示基线GPDd升高独立预测并发症风险增加和无并发症生存期缩短,而FAZe在调整GPDd后无显著关联。

要点

  • 基线GPDd每增加1个标准差(3.62%),并发症风险增加77%(P < .001)。
  • GPDd高组较低组并发症提前117.2天(约4个月)发生(95%CI,-187.7至-46.8;P = .001)。
  • FAZe在调整GPDd后与并发症风险或提早发生无显著关联。

核心结论

  • 基线GPDd升高而非FAZe独立预测DR并发症风险增加和无并发症生存期缩短。
  • GPDd是稳健且时间敏感的生物学标志物,有助于识别需要更密切监测的患者。

研究设计与样本

  • 前瞻性观察队列研究,纳入265只眼(175例患者),覆盖DR严重程度谱。
  • 基线及随访进行眼科评估,GPDd在3×3-mm OCTA深层毛细血管丛图像上量化。
  • 采用Cox回归模型调整年龄、性别、糖化血红蛋白、糖尿病病程和高血压,主要分析排除DR严重程度。

主要发现

  • GPDd每增加1个标准差(3.62%),并发症风险增加77%(P < .001)。
  • GPDd增加1个标准差对应无并发症生存期缩短70天(95%CI,-103.9至-36.0;P < .001)。
  • GPDd高组较低组并发症早发生117.2天(95%CI,-187.7至-46.8;P = .001)。
  • FAZe在调整GPDd后与并发症风险增加或提早发生无显著关联。

关键数值与推荐

  • GPDd定义为距最近灌注毛细血管≥30 µm的视网膜组织百分比,基于3×3-mm OCTA深层毛细血管丛图像。
  • FAZe计算为en face OCT测量的结构FAZ面积与OCTA测量的功能FAZ面积之差。
  • DR并发症定义包括最佳矫正视力下降≥10个字母、DR严重程度进展、玻璃体出血、启动抗VEGF治疗或全视网膜光凝。
  • 高/低生物标志物组采用可转诊DR的最佳Youden J指数截断值定义。

临床怎么用

  • 基线GPDd可用于识别DR并发症高风险患者,提示需要更密切监测。
  • GPDd升高患者可能并发症更早发生,应加强随访频率。

局限性

  • 主要分析因与OCTA指标共线性而排除DR严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate whether diabetic macular ischemia metrics-deep capillary plexus baseline geometric perfusion deficit (GPDd) and foveal avascular zone enlargement (FAZe)-predict the risk and timing of diabetic retinopathy (DR) complications in a 2-year period. DESIGN: A prospective observational cohort study. PARTICIPANTS: A total of 265 eyes (175 patients) across the DR severity spectrum. METHODS: Patients underwent baseline and follow-up ophthalmic evaluations. GPDd was quantified as the percentage of retinal tissue ≥30 µm from the nearest perfused capillary on 3 × 3-mm optical coherence tomography angiography (OCTA) images of the deep capillary plexus. FAZe was calculated as the difference between the structural FAZ area measured on en face OCT and the functional FAZ area measured on OCTA. Time-to-complication analysis was conducted using Cox regression models adjusted for age, sex, glycated hemoglobin, diabetes duration, and hypertension; because of its collinearity with OCTA metrics, DR severity was excluded from the primary analysis. Restricted mean survival time (RMST) quantified the differences in complication-free survival time (days). Kaplan-Meier curves compared survival profiles between high- and low-biomarker groups, defined using the optimal Youden's J-index cutoff for referable DR. MAIN OUTCOME MEASURES: Baseline GPDd and FAZe levels, occurrence of DR complications, and time to the first complication. DR complications were defined as a loss of ≥10-letter best-corrected visual acuity, DR severity progression, vitreous hemorrhage, initiation of an anti-VEGF therapy, or panretinal photocoagulation. RESULTS: Higher baseline GPDd level was associated with both an increased hazard and earlier onset of DR complications. In restricted mean survival time analysis, a +1 SD increase in GPDd corresponded to a 70-day reduction in complication-free survival (95% CI, -103.9 to -36.0; P < .001). When dichotomized into high and low GPDd groups, eyes with high GPDd level developed complications 117.2 days (∼4 months) earlier than those with low GPDd level (95% CI, -187.7 to -46.8; P = .001). In multivariable Cox regression, each 1-SD increase in GPDd (3.62%) was associated with a 77% higher hazard of complications (P < .001). By contrast, FAZe was not significantly associated with an increased hazard or earlier complication onset after adjustment for GPDd. CONCLUSIONS: Elevated GPDd level, but not FAZe, independently predicted an increased complication risk and shorter complication-free survival. GPDd is a robust, time-sensitive biomarker for patients who may benefit from closer monitoring.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zhuang K, Kakihara S, Busza A, et al. Baseline Deep Capillary Plexus Ischemia Predicts Earlier Diabetic Retinopathy Complications Than Foveal Avascular Enlargement. Am J Ophthalmol. 2026. PMID: 42600886. doi:10.1016/j.ajo.2026.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。